EcoDrugPlus

60s Ribosomal Protein L26-Like

Ensembl ID : ENSNBRG00000016596
Gene Symbol: LOC102781305
3 Cross references
477 Possible Orthologues:

60s Ribosomal Protein L28-Like

Ensembl ID : ENSNBRG00000006729
Gene Symbol: LOC102786878
3 Cross references
284 Possible Orthologues:

60s Ribosomal Protein L3-Like

Ensembl ID : ENSNBRG00000006926
Gene Symbol: LOC102789930
3 Cross references
335 Possible Orthologues:

60s Ribosomal Protein L30-Like

Ensembl ID : ENSNBRG00000013468
Gene Symbol: LOC102787549
3 Cross references
415 Possible Orthologues:

60s Ribosomal Protein L31-Like

Ensembl ID : ENSNBRG00000007076
Gene Symbol: LOC102795706
3 Cross references
651 Possible Orthologues:

60s Ribosomal Protein L34-Like

Ensembl ID : ENSNBRG00000008046
Gene Symbol: LOC102777881
3 Cross references
362 Possible Orthologues:

60s Ribosomal Protein L35-Like

Ensembl ID : ENSNBRG00000010485
Gene Symbol: LOC102787793
3 Cross references
274 Possible Orthologues:

60s Ribosomal Protein L35a-Like

Ensembl ID : ENSNBRG00000008805
Gene Symbol: LOC102780861
3 Cross references
452 Possible Orthologues:

60s Ribosomal Protein L36-Like

Ensembl ID : ENSNBRG00000003011
Gene Symbol: LOC102794557
3 Cross references
400 Possible Orthologues:

60s Ribosomal Protein L37-Like

Ensembl ID : ENSNBRG00000006627
Gene Symbol: LOC102785990
3 Cross references
424 Possible Orthologues:

60s Ribosomal Protein L37a-Like

Ensembl ID : ENSNBRG00000015974
Gene Symbol: LOC102787192
4 Cross references
420 Possible Orthologues:

60s Ribosomal Protein L4-A-Like

Ensembl ID : ENSNBRG00000000112
Gene Symbol: LOC102783584
3 Cross references
340 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).